International Assets Investment Management LLC Acquires Shares of 30,296 Encompass Health Co. (NYSE:EHC)

International Assets Investment Management LLC bought a new stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 30,296 shares of the company's stock, valued at approximately $20,210,000.

Other hedge funds also recently made changes to their positions in the company. Baupost Group LLC MA raised its stake in shares of Encompass Health by 318.9% in the first quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company's stock valued at $213,330,000 after buying an additional 2,283,900 shares during the period. Norges Bank purchased a new position in shares of Encompass Health in the fourth quarter worth about $58,988,000. Invesco Ltd. increased its stake in shares of Encompass Health by 22.3% in the third quarter. Invesco Ltd. now owns 3,974,306 shares of the company's stock worth $266,914,000 after purchasing an additional 724,544 shares in the last quarter. Holocene Advisors LP lifted its stake in shares of Encompass Health by 3,070.3% during the 2nd quarter. Holocene Advisors LP now owns 574,171 shares of the company's stock valued at $38,877,000 after buying an additional 556,060 shares in the last quarter. Finally, Millennium Management LLC lifted its stake in shares of Encompass Health by 83.4% during the 4th quarter. Millennium Management LLC now owns 980,352 shares of the company's stock valued at $58,635,000 after buying an additional 445,741 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on EHC shares. Royal Bank of Canada restated an "outperform" rating and set a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Stephens reissued an "overweight" rating and issued a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Mizuho boosted their price objective on shares of Encompass Health from $77.00 to $82.00 and gave the company a "buy" rating in a research note on Friday, February 9th. Barclays increased their target price on shares of Encompass Health from $95.00 to $101.00 and gave the stock an "overweight" rating in a research note on Thursday, March 28th. Finally, William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Wednesday, February 7th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $83.22.

Encompass Health Price Performance

NYSE:EHC traded up $0.08 during midday trading on Thursday, hitting $81.65. The company had a trading volume of 489,804 shares, compared to its average volume of 652,693. The company has a market capitalization of $8.18 billion, a PE ratio of 23.53, a P/E/G ratio of 1.52 and a beta of 0.94. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. Encompass Health Co. has a 52-week low of $57.55 and a 52-week high of $83.73. The stock's fifty day moving average price is $76.51 and its 200-day moving average price is $69.80.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.12. The firm had revenue of $1.25 billion during the quarter, compared to analysts' expectations of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. As a group, research analysts expect that Encompass Health Co. will post 3.96 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 15th. Stockholders of record on Monday, April 1st will be issued a $0.15 dividend. The ex-dividend date is Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.73%. Encompass Health's payout ratio is 17.29%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.